Literature DB >> 9733900

Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter.

M A Montano1, C P Nixon, M Essex.   

Abstract

The global diversity of human immunodeficiency virus type 1 (HIV-1) genotypes, termed subtypes A to J, is considerable and growing. However, relatively few studies have provided evidence for an associated phenotypic divergence. Recently, we demonstrated subtype-specific functional differences within the long terminal repeat (LTR) region of expanding subtypes (M. A. Montano, V. A. Novitsky, J. T. Blackard, N. L. Cho, D. A. Katzenstein, and M. Essex, J. Virol. 71:8657-8665, 1997). Notably, all HIV-1E isolates were observed to contain a defective upstream NF-kappaB site and a unique TATA-TAR region. In this study, we demonstrate that tumor necrosis factor alpha (TNF-alpha) stimulation of the HIV-1E LTR was also impaired, consistent with a defective upstream NF-kappaB site. Furthermore, repair of the upstream NF-kappaB site within HIV-1E partially restored TNF-alpha responsiveness. We also show, in gel shift assays, that oligonucleotides spanning the HIV-1E TATA box displayed a reduced efficiency in the assembly of the TBP-TFIIB-TATA complex, relative to an HIV-1B TATA oligonucleotide. In transfection assays, the HIV-1E TATA, when changed to the canonical HIV-1B TATA sequence (ATAAAA-->ATATAA) unexpectedly reduces both heterologous HIV-1B Tat and cognate HIV-1E Tat activation of an HIV-1E LTR-driven reporter gene. However, Tat activation, irrespective of subtype, could be rescued by introducing a cognate HIV-1B TAR. Collectively, these observations suggest that the expanding HIV-1E genotype has likely evolved an alternative promoter configuration with altered NF-kappaB and TATA regulatory signals in contradistinction with HIV-1B.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733900      PMCID: PMC110241     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India.

Authors:  S Tripathy; B Renjifo; W K Wang; M F McLane; R Bollinger; J Rodrigues; J Osterman; S Tripathy; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  1996-08-10       Impact factor: 2.205

2.  Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking.

Authors:  Z Wang; X Wang; T M Rana
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

Review 3.  The role of general initiation factors in transcription by RNA polymerase II.

Authors:  R G Roeder
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

4.  HIV-1 subtypes in different risk groups in South Africa.

Authors:  C Williamson; S Engelbrecht; M Lambrick; E J van Rensburg; R Wood; W Bredell; A L Williamson
Journal:  Lancet       Date:  1995-09-16       Impact factor: 79.321

5.  Recombination in HIV-1.

Authors:  D L Robertson; P M Sharp; F E McCutchan; B H Hahn
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

6.  Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.

Authors:  Y Liu; Z Wang; T M Rana
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

7.  Recombination in AIDS viruses.

Authors:  D L Robertson; B H Hahn; P M Sharp
Journal:  J Mol Evol       Date:  1995-03       Impact factor: 2.395

8.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Authors:  R Marlink; P Kanki; I Thior; K Travers; G Eisen; T Siby; I Traore; C C Hsieh; M C Dia; E H Gueye
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

9.  Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin.

Authors:  J Louwagie; W Janssens; J Mascola; L Heyndrickx; P Hegerich; G van der Groen; F E McCutchan; D S Burke
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.

Authors:  F Gao; D L Robertson; S G Morrison; H Hui; S Craig; J Decker; P N Fultz; M Girard; G M Shaw; B H Hahn; P M Sharp
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  20 in total

1.  Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Authors:  V A Novitsky; M A Montano; M F McLane; B Renjifo; F Vannberg; B T Foley; T P Ndung'u; M Rahman; M J Makhema; R Marlink; M Essex
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

4.  Use of ATP analogs to inhibit HIV-1 transcription.

Authors:  Aarthi Narayanan; Gavin Sampey; Rachel Van Duyne; Irene Guendel; Kylene Kehn-Hall; Jessica Roman; Robert Currer; Hervé Galons; Nassima Oumata; Benoît Joseph; Laurent Meijer; Massimo Caputi; Sergei Nekhai; Fatah Kashanchi
Journal:  Virology       Date:  2012-07-06       Impact factor: 3.616

5.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Authors:  R E Jeeninga; M Hoogenkamp; M Armand-Ugon; M de Baar; K Verhoef; B Berkhout
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.

Authors:  Tim van Opijnen; Joost Kamoschinski; Rienk E Jeeninga; Ben Berkhout
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.

Authors:  K Verhoef; R W Sanders; V Fontaine; S Kitajima; B Berkhout
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.

Authors:  Tim van Opijnen; Rienk E Jeeninga; Maarten C Boerlijst; Georgios P Pollakis; Veera Zetterberg; Mika Salminen; Ben Berkhout
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.

Authors:  Roshni Mehta; Vasudha Sundaravaradan; Nafees Ahmad
Journal:  Virology       Date:  2008-03-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.